Summary
Between October 1979 and March 1982, bone marrow transplantations were performed by the Tübingen Group for BMT on 19 patients with acute leukemia in remission and on one patient with chronic myelocytic leukemia in chronic phase. The conditioning regimen consisted of 2×60 mg cyclophosphamide/kg and 10 Gy whole-body irradiation with the linear accelerator. The lung dose was limited by shielding to 8 Gy. In 15 patients, the bone marrow cell suspension of the donor was preincubated with antihuman T-cell globulin (AHTCG) for prophylaxis of graft-versus-host disease (GVHD). All patients showed prompt engraftment of donor cells with good hemopoietic function and complete chimerism. Under reverse isolation in sterile units, no severe bacterial or fungal infections were seen in the phase of bone marrow aplasia.
Twelve in twenty patients survived between 25 and 900 days. A severe GVHD was seen only in two patients — one after preincubation with AHTCG. One patient died from relapse of his leukemia, another patient had a testicular relapse which was treated with local radiotherapy. Major problems were seen with chronic GVHD (six patients) and infectious complications, most importantly interstitial pneumonia, in the late post-transplant period.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AHTCG:
-
Anti-Human-T-Zell-Globulin [11]
- ALL:
-
Akute lymphatische Leukämie
- AML:
-
Akute myeloische Leukämie
- AMML:
-
Akute myelomonozytäre Leukämie
- AUL:
-
Akute undifferenzierte Leukämie
- GVHD:
-
Graftversus-Host-Krankheit
- CML:
-
Chronische myeloische Leukämie
- HLA:
-
Human leukocyte antigen
- KMT:
-
Knochenmarktransplantation
- MLC:
-
„mixed leukocyte culture“
Literatur
Bekkum WD van (1974) The double barrier in bone marrow transplantation. Semin Hematol 11:325–336
Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Froman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL (1980) Bone marrow ablation and allogenic marrow transplantation in acute leukemia. N Engl J Med 302:1041–1046
Bortin MM, Kay HEM, Gale RP, Rimm A (1982) Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Lancet I:437–439
Doney K, Buckner CD, Sale GE, Ramberg R, Boyd C, Thomas ED (1978) Treatment of chronic granulocytic leukemia by chemotherapy, total body irradiation and allogeneic bone marrow transplantation. Exp Hematol 6:738–747
Fefer A, Cheever MA, Thomas ED, Boyd C, Ramberg R, Glucksberg H, Buckner CD, Storb R (1979) Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. N Engl J Med 300:333–337
Gale RP, Feig S, Opelz G, Territo M, Young L, Sarna G, Fahey J, Cline MJ, and the UCLA Bone Marrow Transplant Team (1976) Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARIUCLA). Transplant Proc 8:611–616
Link H, Neff V, Niethammer D, Wilms K (1981) Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bonemarrow transplantation. Blut 43:329–330
Lorenz E, Uphoff D, Reid TR (1951) Modification of radiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 12:197–206
Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HEM, Lawson D, McElwain TJ, Alexander P (1980a) Cyclosporin A to prevent graft-versushost disease in man after allogeneic bonemarrow transplantation. Lancet I:327–329
Powles RL, Clink HM, Bandini G, Watson JG, Spence D, Jameson B, Kay HEM, Morgenstern G, Hedley D, Lumley H, Lawson D, Barrett A, Lawler S, McElwain FJ (1980b) The place of bone marrow transplantation in acute myelogenous leukaemia. Lancet I:1047–1050
Rodt H, Netzel B, Kolb HJ, Haas RJ, Wilms K, Bender-Götze C, Wernet P, Janka G, Link H, Wilmanns W, Thierfelder S (1981) Knochenmarktransplantation bei akuter Leukämie: Prophylaktische Antiserumbehandlung des Knochenmarks zur Unterdrückung einer Transplantat-gegen-Wirt-Reaktion. Blut 43:113–118
Schneider W, Stützle G (1979) Neues Verfahren zur Herstellung von leukozyten-, thrombozytenarmen Erythrozytensedimenten. Med Welt 30:1597–1601
Shulman HM, Sullivan KM, Weiden P, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED (1980) Chronic graft-versus-host syndrome in man: A clinicopathological study of 20 long-term Seattle patients. Am J Med 69:204–217
Speck B, Gratwohl A, Nissen C, Osterwalder B, Müller M, Lüthy A, Signer E, Burri HP, Jeannet M (1981) Neue Entwicklung in der klinischen Knochenmarktransplantation bei Leukämie. Schweiz Med Wochenschr 111:1975–1977
Sullivan KM, Shulman HM, Storb R, Weiden P, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED (1981) Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267–276
Thomas ED, Storb R (1970) Technique for human marrow grafting. Blood 36:507–512
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone marrow transplantation. N Engl J Med 292:823–843
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodwell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Stevens M, Storb R, Weiden P (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:511–520
Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GS, Sanders JE, Singer JW, Shulman H, Storb R, Weiden P (1979a) Marrow transplantation for acute nonlymphocytic leukemia in first remission. N Engl J Med 301:597–599
Thomas ED, Sanders JE, Flournoy N, Johnson FL, Buckner CD, Clift RA, Fefer A, Goodwell BW, Storb R, Weiden P (1979b) Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54:468–476
Thomas ED (1981) Bonemarrow transplantation. In: Burchenal JH, Oettgen HF (eds) Cancer II. Grune & Stratton, New York London Toronto, pp 625–638
Wilms K, Meyer P, Bader R-E (1977) Umkehrisolation in Sterileinheiten zur Infektionsprophylaxe bei Patienten mit schwerer Knochenmarkinsuffizienz. Internist 18:399–406
Wilms K, Link H, Meyer P, Ostendorf P, Schüch K, Wernet P, Waller HD, Niethammer D, Dopfer H, Treuner J, Schneider W, Schunter F, Breitling C, Frommhold W, Voss AC (1982) Knochenmarktransplantation bei akuter Leukämie: Therapeutischer Ausweg oder kuratives Therapiekonzept? Beitr zur Onkologie (im Druck)
Zwaan FE, for the EBMT (1982) Marrow grafting for acute leukemia during remission — results of European groups. VIth European Symposium on bone marrow transplantation, Courmayeur. Exp. Hematol [Suppl] 10:64–69
Author information
Authors and Affiliations
Additional information
Herrn Prof. Dr. G.W. Löhr, Freiburg, zum 60. Geburtstag gewidemet
Mit Unterstützung durch die Deutsche Forschungsgemeinschaft, DFG-Forschergruppe „Leukämieforschung“, Wa 139/11-Wa 139/13-5
Rights and permissions
About this article
Cite this article
Wilms, K., Link, H., Meyer, P. et al. Knochenmarktransplantation bei Patienten mit Leukämien. Klin Wochenschr 60, 1279–1287 (1982). https://doi.org/10.1007/BF01727484
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01727484